QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.

Journal of Child and Adolescent PsychopharmacologyVol. 18, No. 4 BRIEF REPORTSQTc Changes after 6 Months of Second-Generation Antipsychotic Treatment in Children and AdolescentsMaría J. de Castro, David Fraguas, Paula Laita, Dolores Moreno, Mara Parellada, David Pascual, Mar Álvarez, Jessica Merchán-Naranjo, Marta Rapado, Marisa Giráldez, Marta Leiva, and Celso ArangoMaría J. de CastroSearch for more papers by this author, David FraguasSearch for more papers by this author, Paula LaitaSearch for more papers by this author, Dolores MorenoSearch for more papers by this author, Mara ParelladaSearch for more papers by this author, David PascualSearch for more papers by this author, Mar ÁlvarezSearch for more papers by this author, Jessica Merchán-NaranjoSearch for more papers by this author, Marta RapadoSearch for more papers by this author, Marisa GiráldezSearch for more papers by this author, Marta LeivaSearch for more papers by this author, and Celso ArangoSearch for more papers by this authorPublished Online:30 Aug 2008https://doi.org/10.1089/cap.2007.0115AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byLagging skills contribute to challenging behaviors in children with autism spectrum disorder without intellectual disability26 August 2017 | Autism, Vol. 22, No. 8The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorderJournal of Electrocardiology, Vol. 50, No. 4Risperidone and Cardiometabolic Risk in Children and AdolescentsJournal of Clinical Psychopharmacology, Vol. 37, No. 3Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study17 June 2016 | Journal of Child and Adolescent Psychopharmacology, Vol. 26, No. 5QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review29 August 2014 | CNS Drugs, Vol. 28, No. 10Antipsychotics use in children and adolescents: An on-going challenge in clinical practice5 June 2014 | Journal of Psychopharmacology, Vol. 28, No. 7ECG parameters in children and adolescents treated with aripiprazole and risperidoneProgress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 51Prescriptions d'antipsychotiques chez l'enfant et l'adolescentEMC - Psychiatrie, Vol. 8, No. 4Principes de surveillance des effets métaboliques, de l’hyperprolactinémie et du rythme cardiaque pour les antipsychotiques atypiques chez l’enfant et l’adolescentNeuropsychiatrie de l'Enfance et de l'Adolescence, Vol. 58, No. 6-7Current awareness: Pharmacoepidemiology and drug safetyPharmacoepidemiology and Drug Safety, Vol. 18, No. 2 Volume 18Issue 4Aug 2008 Information© 2008 Mary Ann Liebert, Inc.To cite this article:María J. de Castro, David Fraguas, Paula Laita, Dolores Moreno, Mara Parellada, David Pascual, Mar Álvarez, Jessica Merchán-Naranjo, Marta Rapado, Marisa Giráldez, Marta Leiva, and Celso Arango.QTc Changes after 6 Months of Second-Generation Antipsychotic Treatment in Children and Adolescents.Journal of Child and Adolescent Psychopharmacology.Aug 2008.381-383.http://doi.org/10.1089/cap.2007.0115Published in Volume: 18 Issue 4: August 30, 2008PDF download